Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Investigating ECM changes in the hypothalamus reveals mechanisms behind insulin resistance, offering insights into obesity ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...

Ozempic is not approved for use in weight loss, however, many people have been taking the drug for this purpose. Semaglutide was approved for weight loss purposes under another name—Wegovy—which has a ...

Researchers from the University of Maryland have discovered that antacids, commonly used to treat heartburn and indigestion, ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

The global insulin pumps market, valued at USD 5.5 billion in 2022, is poised for remarkable growth, with an anticipated ...

“Glucose-responsive – so-called smart – insulins are regarded as the holy grail of insulin as they would come as close to a ...